University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 21 of 29
TMS as a Biological Marker of Neuroplasticity
NCT02867670
Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic Disease
NCT01900470
Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer
NCT01897415
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
NCT01899001
Habit Formation for Adherence to Statin Use and LDL Reduction
NCT01798784
Targeting the Right Ventricle in Pulmonary Hypertension
NCT01839110
T1Rho MRI Evaluation of Patellofemoral Changes After Tibial IM Nailing
NCT01879215
Partners and Alerts: A Study of Social Forces in Medication Adherence
NCT01890018
Treatment Preference and Patient Centered Prostate Cancer Care
NCT02032550
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
NCT01879228
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
NCT01611935
Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)
NCT01778933
Foley OR MisO for the Management of Induction
NCT01916681
cMet CAR RNA T Cells Targeting Breast Cancer
NCT01837602
Vascular Inflammation in Psoriasis - Extension Study
NCT01866592
UPHS Weight Loss Study
NCT01800591
Improving Syncope Risk Stratification in Older Adults
NCT01802398
Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong)
NCT01800201
Understanding the Sleep Apnea/Insomnia Interaction
NCT01824472
Probability Ramp Control of Propofol for EGD
NCT01838304
Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes
NCT01975792
Baclofen Effects in Cigarette Smokers
NCT01821560
Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
NCT01756053
Why Join a Walking Program?
NCT01730703
Ghrelin Repeated Dose Study
NCT01833078
Influence of Peer Mentoring on Adolescent Contraceptive Decision Making
NCT02157285
Nicotine Receptor Levels and Smoking Cessation
NCT01788943
Remote Observed Dosing to Increase Suboxone Compliance
NCT01779973
RCT for Women With a Persisting Pregnancy of Unknown Location
NCT01800162
Dose Optimization Trial of CD19 Redirected Autologous T Cells
NCT01747486
Communicating Smoking Risks Through Graphic Warning Labels
NCT01782053
Effect of Insulin Sensitizer Metformin on AD Biomarkers
NCT01965756
Extended Varenicline Treatment for Smoking Among Cancer Patients
NCT01756885
PAD Registry and Fitbit Sub-Study Program
NCT03446014
Buy 1 Get 1: Role of Grocery Coupons in Promoting Obesogenic Home Food Environments and Eating Behaviors
NCT01710124
Screening To Obviate Preterm Birth
NCT01868308
A Test of Different Degrees of Cost Sharing on Program Uptake and Attendance
NCT01756066
Clinical and Biochemical Evidence of Neurogenic Inflammation in Women With Urinary Urgency
NCT01933074
Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
NCT01600170
Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy
NCT01973374
miRNA in Fetal Overgrowth
NCT01935076
Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia
NCT02011607
Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
NCT01965730
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers
NCT01764685
Effects of Niacin On Fatty Acid Trapping
NCT01984073
Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy
NCT01787994
Nicotine Metabolism and Little Cigars
NCT01898559
Vilazodone for Menopausal Hot Flashes
NCT01680900
Effects of Repeated Decision Making Among Surrogates of Seriously Ill Patients
NCT01723436
Effects of Frequent Decision Making Among Patients With Serious Illnesses
NCT01722123
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.